31. P-88 First-Line Pembrolizumab With or Without Lenvatinib in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 3 LEAP-010 Study. (July 2021) Authors: Harrington, Kevin; Siu, Lillian L.; Burtness, Barbara; Cohen, Ezra; Licitra, Lisa; Rischin, Danny; Zhu, Ying; Okpara, Chinyere E.; Pinheiro, Cecilia; Swaby, Ramona F.; Machiels, Jean-Pascal; Tahara, Makoto Journal: Oral oncology Issue: Volume 118(2021)Supplement Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. P-94 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009. (July 2021) Authors: Harrington, Kevin J.; Cohen, Ezra E.W.; Siu, Lillian; Rischin, Danny; Licitra, Lisa; Vermorken, Jan; Le, Quynh; Tahara, Makoto; Machiels, Jean-Pascal; Hawk, Natalyn; Ge, Joy; Bidadi, Behzad; Swaby, Ramona F.; Burtness, Barbara Journal: Oral oncology Issue: Volume 118(2021)Supplement Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. Issue 7 (July 2021) Authors: Powles, Thomas; Csőszi, Tibor; Özgüroğlu, Mustafa; Matsubara, Nobuaki; Géczi, Lajos; Cheng, Susanna Y-S; Fradet, Yves; Oudard, Stephane; Vulsteke, Christof; Morales Barrera, Rafael; Fléchon, Aude; Gunduz, Seyda; Loriot, Yohann; Rodriguez-Vida, Alejo; Mamtani, Ronac; Yu, Evan Y; Nam, Kijoeng; Imai... Journal: Lancet oncology Issue: Volume 22:Issue 7(2021) Page Start: 931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Issue 10167 (12th January 2019) Authors: Cohen, Ezra E W; Soulières, Denis; Le Tourneau, Christophe; Dinis, José; Licitra, Lisa; Ahn, Myung-Ju; Soria, Ainara; Machiels, Jean-Pascal; Mach, Nicolas; Mehra, Ranee; Burtness, Barbara; Zhang, Pingye; Cheng, Jonathan; Swaby, Ramona F; Harrington, Kevin J Journal: Lancet Issue: Volume 393:Issue 10167(2019) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer. (18th April 2016) Authors: Agarwal, Neeraj; Machiels, Jean-Pascal; Suárez, Cristina; Lewis, Nancy; Higgins, Michaela; Wisinski, Kari; Awada, Ahmad; Maur, Michela; Stein, Mark; Hwang, Andy; Mosher, Rebecca; Wasserman, Ernesto; Wu, Gang; Zhang, Hefei; Zieba, Renata; Elmeliegy, Mohamed Journal: Oncologist Issue: Volume 21:Number 5(2016) Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer. (May 2017) Authors: Massard, Christophe; Chi, Kim Nguyen; Castellano, Daniel; de Bono, Johann; Gravis, Gwenaelle; Dirix, Luc; Machiels, Jean-Pascal; Mita, Alain; Mellado, Begoña; Turri, Sabine; Maier, Joan; Csonka, Denes; Chakravartty, Arunava; Fizazi, Karim Journal: European journal of cancer Issue: Volume 76(2017) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer. (May 2017) Authors: Massard, Christophe; Chi, Kim Nguyen; Castellano, Daniel; de Bono, Johann; Gravis, Gwenaelle; Dirix, Luc; Machiels, Jean-Pascal; Mita, Alain; Gonzalez, Begona Mellado; Turri, Sabine; Maier, Joan; Csonka, Denes; Chakravartty, Arunava; Fizazi, Karim Journal: European journal of cancer Issue: Volume 76(2017) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients. Issue 2 (23rd October 2020) Authors: Machiels, Jean-Pascal; Gomez-Roca, Carlos; Michot, Jean-Marie; Zamarin, Dmitriy; Mitchell, Tara; Catala, Gaetan; Eberst, Lauriane; Jacob, Wolfgang; Jegg, Anna-Maria; Cannarile, Michael A; Watson, Carl; Babitzki, Galina; Korski, Konstanty; Klaman, Irina; Teixeira, Priscila; Hoves, Sabine; Ries, Ca... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients. Issue 2 (23rd October 2020) Authors: Machiels, Jean-Pascal; Gomez-Roca, Carlos; Michot, Jean-Marie; Zamarin, Dmitriy; Mitchell, Tara; Catala, Gaetan; Eberst, Lauriane; Jacob, Wolfgang; Jegg, Anna-Maria; Cannarile, Michael A; Watson, Carl; Babitzki, Galina; Korski, Konstanty; Klaman, Irina; Teixeira, Priscila; Hoves, Sabine; Ries, Ca... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients. Issue 2 (23rd October 2020) Authors: Machiels, Jean-Pascal; Gomez-Roca, Carlos; Michot, Jean-Marie; Zamarin, Dmitriy; Mitchell, Tara; Catala, Gaetan; Eberst, Lauriane; Jacob, Wolfgang; Jegg, Anna-Maria; Cannarile, Michael A; Watson, Carl; Babitzki, Galina; Korski, Konstanty; Klaman, Irina; Teixeira, Priscila; Hoves, Sabine; Ries, Ca... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗